Moolchan ET - Search Results

1

Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration.

Kacinko SL, Barnes AJ, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Kacinko SL, et al. Among authors: moolchan et. Clin Chem. 2005 Nov;51(11):2085-94. doi: 10.1373/clinchem.2005.054338. Epub 2005 Sep 15. Clin Chem. 2005. PMID: 16166169 Clinical Trial.

2

Urinary elimination of cocaine metabolites in chronic cocaine users during cessation.

Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET. Preston KL, et al. Among authors: moolchan et. J Anal Toxicol. 2002 Oct;26(7):393-400. doi: 10.1093/jat/26.7.393. J Anal Toxicol. 2002. PMID: 12422991

3

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.

Schepers RJ, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, Huestis MA. Schepers RJ, et al. Among authors: moolchan et. Clin Chem. 2003 Jan;49(1):121-32. doi: 10.1373/49.1.121. Clin Chem. 2003. PMID: 12507968 Clinical Trial.

4

Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.

Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Gustafson RA, et al. Among authors: moolchan et. Clin Chem. 2003 Jul;49(7):1114-24. doi: 10.1373/49.7.1114. Clin Chem. 2003. PMID: 12816908 Clinical Trial.

5

Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs.

Kim I, Barnes AJ, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Kim I, et al. Among authors: moolchan et. Clin Chem. 2003 Sep;49(9):1498-503. doi: 10.1373/49.9.1498. Clin Chem. 2003. PMID: 12928231

6

Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration.

Barnes AJ, Kim I, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Barnes AJ, et al. Among authors: moolchan et. J Anal Toxicol. 2003 Oct;27(7):402-7. doi: 10.1093/jat/27.7.402. J Anal Toxicol. 2003. PMID: 14606992

7

Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration.

Kolbrich EA, Kim I, Barnes AJ, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Kolbrich EA, et al. Among authors: moolchan et. J Anal Toxicol. 2003 Oct;27(7):407-11. doi: 10.1093/jat/27.7.407. J Anal Toxicol. 2003. PMID: 14606993

8

Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.

Kacinko SL, Barnes AJ, Kim I, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Kacinko SL, et al. Among authors: moolchan et. Forensic Sci Int. 2004 Apr 20;141(1):41-8. doi: 10.1016/j.forsciint.2003.12.003. Forensic Sci Int. 2004. PMID: 15066713

9

Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans.

Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA. Kim I, et al. Among authors: moolchan et. Ther Drug Monit. 2004 Dec;26(6):664-72. doi: 10.1097/00007691-200412000-00013. Ther Drug Monit. 2004. PMID: 15570192 Clinical Trial.

10

Scheidweiler KB, Cone EJ, Moolchan ET, Huestis MA. Scheidweiler KB, et al. Among authors: moolchan et. J Pharmacol Exp Ther. 2005 May;313(2):909-15. doi: 10.1124/jpet.104.082388. Epub 2005 Mar 2. J Pharmacol Exp Ther. 2005. PMID: 15743923 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page